The Chinese University of Hong Kong
π¨π³China
- Country
- π¨π³China
- Ownership
- Private
- Established
- 1963-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.cuhk.edu.hk
Natural History of Non-steroidal Anti-inflammatory Drug and Non-Helicobacter Pylori in Bleeding Peptic Ulcers
Completed
- Conditions
- Peptic Ulcer
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2017-08-17
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 391
- Registration Number
- NCT00153712
- Locations
- π¨π³
Endoscopy Center, Prince of Wales Hospital, Shatin, Hong Kong, China
The Efficacy of Herbal Medicine in Relieving Symptoms and Change of Quality of Life of Patients With Irritable Bowel Syndrome (IBS)
Phase 2
Completed
- Conditions
- Colonic Diseases, Functional
- Interventions
- Drug: HoloponOther: placeboDrug: Traditional Chinese Medicine
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-05-13
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 84
- Registration Number
- NCT00153751
- Locations
- π¨π³
Li Ka Shing Specialist Clinic, Prince of Wales Hospital, Hong Kong (SAR), China
Gabapentin for Carpal Tunnel Syndrome
- First Posted Date
- 2005-08-30
- Last Posted Date
- 2007-10-31
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 150
- Registration Number
- NCT00137735
- Locations
- ππ°
Prince of Wales Hospital, Shatin, New Territories, Hong Kong
ππ°North District Hospital, Sheung Shui, New Territories, Hong Kong
Hormone Profiles in Adults With Newly Diagnosed Epilepsy
Phase 4
- Conditions
- Epilepsy
- First Posted Date
- 2005-08-30
- Last Posted Date
- 2007-10-31
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 80
- Registration Number
- NCT00137709
- Locations
- ππ°
Prince of Wales Hospital, Shatin, Hong Kong
ππ°United Christian Hospital, Kowloon, Hong Kong
Does Extra-High Dose Hepatitis B Vaccination Confer Longer Serological Protection in Peritoneal Dialysis Patients?
Phase 4
Completed
- Conditions
- Peritoneal DialysisRenal Disease, End-Stage
- Interventions
- Biological: Engerix-B
- First Posted Date
- 2005-08-02
- Last Posted Date
- 2010-01-07
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 130
- Registration Number
- NCT00125775
- Locations
- ππ°
Prince of Wales Hospital, New Territories, Hong Kong
Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis
Phase 4
Completed
- Conditions
- Lupus NephritisLupus Erythematosus, Systemic
- First Posted Date
- 2005-08-01
- Last Posted Date
- 2015-08-03
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 20
- Registration Number
- NCT00125307
- Locations
- ππ°
Department of Medicine & Therapeutics, Prince of Wales Hospital, Shatin, Hong Kong
Intravenous Magnesium Sulfate in Aneurysmal Subarachnoid Haemorrhage (IMASH)
Phase 3
Completed
- Conditions
- Subarachnoid Hemorrhage
- Interventions
- Drug: Intravenous magnesium sulfate infusion
- First Posted Date
- 2005-07-27
- Last Posted Date
- 2009-12-23
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 327
- Registration Number
- NCT00124150
- Locations
- π¨π³
Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China
Treatment of Tennis Elbow With Botulinum Toxin
Phase 3
Completed
- Conditions
- Epicondylitis, Lateral Humeral
- First Posted Date
- 2005-07-14
- Last Posted Date
- 2006-05-09
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 60
- Registration Number
- NCT00119704
- Locations
- ππ°
Prince of Wales Hospital, Shatin, New Territories, Hong Kong
ππ°North District Hospital, Sheung Shui, New Territories, Hong Kong
Β© Copyright 2025. All Rights Reserved by MedPath